Literature DB >> 24092899

Direct access to physical therapy for patients with low back pain in the Netherlands: prevalence and predictors.

Jantine Scheele1, Frank Vijfvinkel, Marijn Rigter, Ilse C S Swinkels, Sita M A Bierman-Zeinstra, Bart W Koes, Pim A J Luijsterburg.   

Abstract

BACKGROUND: In the Netherlands, direct access to physical therapy was introduced in 2006. Although many patients with back pain visit physical therapists through direct access, the frequency and characteristics of episodes of care are unknown.
OBJECTIVE: The purposes of this study were: (1) to investigate the prevalence of direct access to physical therapy for patients with low back pain in the Netherlands from 2006 to 2009, (2) to examine associations between mode of access (direct versus referral) and patient characteristics, and (3) to describe the severity of the back complaints at the beginning and end of treatment for direct access and referral-based physical therapy.
DESIGN: A cross-sectional study was conducted using registration data of physical therapists obtained from a longitudinal study.
METHOD: Data were used from the National Information Service for Allied Health Care, a registration network of Dutch physical therapists. Mode of access (direct or referral) was registered for each episode of physical therapy care due to back pain from 2006 to 2009. Logistic regression analysis was used to explore associations between mode of access and patient/clinical characteristics.
RESULTS: The percentage of episodes of care for which patients with back pain directly accessed a physical therapist increased from 28.9% in 2006 to 52.1% in 2009. Characteristics associated with direct access were: middle or higher education level (odds ratio [OR]=1.3 and 2.0, respectively), previous physical therapy care (OR=1.7), recurrent back pain (OR=1.7), duration of back pain <7 days (OR=4.2), and age >55 years (OR=0.6). LIMITATIONS: The study could not compare outcomes of physical therapy care by mode of access because this information was not registered from the beginning of data collection and, therefore, was missing for too many cases.
CONCLUSIONS: Direct access was used for an increasing percentage of episodes of physical therapy care in the years 2006 to 2009. Patient/clinical characteristics associated with the mode of access were education level, recurrent back pain, previous physical therapy sessions, and age.

Entities:  

Mesh:

Year:  2013        PMID: 24092899     DOI: 10.2522/ptj.20120330

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  5 in total

1.  Implementing patient direct access to musculoskeletal physiotherapy in primary care: views of patients, general practitioners, physiotherapists and clinical commissioners in England.

Authors:  Chinonso N Igwesi-Chidobe; Annette Bishop; Katrina Humphreys; Emily Hughes; Joanne Protheroe; John Maddison; Bernadette Bartlam
Journal:  Physiotherapy       Date:  2020-07-11       Impact factor: 3.358

2.  Treatment of hip/knee osteoarthritis in Dutch general practice and physical therapy practice: an observational study.

Authors:  Di-Janne J A Barten; Llse C S Swinkels; Sara A Dorsman; Joost Dekker; Cindy Veenhof; Dinny H de Bakker
Journal:  BMC Fam Pract       Date:  2015-06-27       Impact factor: 2.497

Review 3.  Direct access to physical therapy for the patient with musculoskeletal disorders, a literature review.

Authors:  Leonardo Piano; Filippo Maselli; Antonello Viceconti; Silvia Gianola; Aldo Ciuro
Journal:  J Phys Ther Sci       Date:  2017-08-10

4.  Implementation of a Multidisciplinary Guideline for Low Back Pain: Process-Evaluation Among Health Care Professionals.

Authors:  Arnela Suman; Frederieke G Schaafsma; Rachelle Buchbinder; Maurits W van Tulder; Johannes R Anema
Journal:  J Occup Rehabil       Date:  2017-09

5.  Use and perceived added value of patient-reported measurement instruments by physiotherapists treating acute low back pain: a survey study among Dutch physiotherapists.

Authors:  J Knoop; W van Lankveld; F J B Geerdink; R Soer; J B Staal
Journal:  BMC Musculoskelet Disord       Date:  2020-02-24       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.